HIRAN ALFONSO: Open Payments
NPI 1083372098 · JUPITER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,108 in 105 payments from 16 companies in 2025. Trend: 2023 $15 · 2024 $0 · 2025 $2,108
Food & beverage: $2,108
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 17 | $356 |
| ABBVIE INC. | 20 | $299 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $299 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $191 |
| Neurocrine BioSciences, Inc. | 7 | $173 |
| Otsuka America Pharmaceutical, Inc. | 7 | $137 |
| Axsome Therapeutics, Inc. | 5 | $137 |
| Vanda Pharmaceuticals Inc. | 7 | $132 |
| Corium, LLC | 5 | $89 |
| Tris Pharma Inc | 4 | $82 |
Products named: VRAYLAR, CAPLYTA, ARISTADA, TRINTELLIX, REXULTI, INGREZZA, Auvelity, FANAPT.
Industry payments across FL — which companies pay providers there.
